Subscribe

Singular Health Group Ltd (SHG.AX)

AUD0.21 -0.01 (-2.33%)
AU ASX Healthcare Medical - Healthcare Information Services
Address 26 Railway Road 6008
Bibra Lake, WA, AU
CEO Denning Chong
IPO 2021-02-11
ISIN AU0000129892

Explore sections of this company profile

Description

Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anatomy, drawing upon standard radiological imaging. Among its key offerings are the 3Dicom Viewer, a cross-compatible software application designed for users to engage with conventional 2D medical images; 3DicomVSP, a complete system for surgical planning; Health Academy, a adaptable, multi-language platform delivering structured, curriculum-aligned educational modules; and GeoVR, a cloud-based solution specifically engineered for the mineral resources industry. The company, founded in 2017, is headquartered in Subiaco, Australia.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
AUD0.21 -0.01 (-2.33%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
347.6K
Beta
0.01
Float Shares
217.90M
Free Float %
68.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-11.36% -2.50% -9.30% -26.42% -29.09% -23.53% -35.00% +254.55% -48.00% -48.68% -48.68%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.21
DCF (Unlevered) 0.03 -84.2%
DCF (Levered) 0.01 -95.3%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
39.05
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Healthcare Information Services: +14.2%
    -40.3% Q4'25: +264.5% (vs Q4'23)
  • EPS growth Medical - Healthcare Information Services: +43.1%
    -46.7% Q4'25: -65.5% (vs Q4'23)
  • FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    -1,159.0% Q4'25: -672.9% (vs Q4'23)
  • EBIT margin Medical - Healthcare Information Services: +8.8%
    -1,147.1% Q4'25: -768.7% (vs Q4'23)
  • ROIC Medical - Healthcare Information Services: +5.2%
    Q4'25: -1,977.1% (vs Q4'23)
  • Share dilution Medical - Healthcare Information Services: -0.1%
    +48.0% Q4'25: +120.6% (vs Q4'23)
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.00× Q4'25: -0.01× (vs Q4'23)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.01) × ERP
WACC = 100% × Ke + 0% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 0.03 Current price: 0.21
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-28 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-27 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-26 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-25 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-22 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-21 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-20 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-19 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-18 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-15 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-14 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-13 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-12 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-11 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-08 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-07 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-06 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-05 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-04 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-01 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-30 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-29 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-28 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-27 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-24 C 2/5 3/5 1/5 1/5 3/5 1/5 1/5
2026-04-23 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-22 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-21 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-20 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-17 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-16 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-6.66M
OE per share TTM
-0.03
Owner's Yield
-11.05%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
70.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-8.0K
Shares Outstanding
316.32M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Denning Chong Co-Founder, MD, Chief Executive Officer & Executive Director 467.5K male
Martina Mariano Chief Operating Officer 200.3K female
Kyla Garic Chief Financial Officer female
Paige Taylor Chief Commercial Officer female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits